APA (7th ed.) Citation

K, O. W., KA, M., L, C., R, K., K, G., J, H., . . . S, S. (2025). Preclinical Evaluation of Novel SGLT2-Targeted Near-Infrared Optical Imaging Agent for Early-Stage Pulmonary Adenocarcinoma. Molecular imaging and biology, 27(4), 558. https://doi.org/10.1007/s11307-025-02029-w

Chicago Style (17th ed.) Citation

K, Ortmeyer Welch, et al. "Preclinical Evaluation of Novel SGLT2-Targeted Near-Infrared Optical Imaging Agent for Early-Stage Pulmonary Adenocarcinoma." Molecular Imaging and Biology 27, no. 4 (2025): 558. https://doi.org/10.1007/s11307-025-02029-w.

MLA (9th ed.) Citation

K, Ortmeyer Welch, et al. "Preclinical Evaluation of Novel SGLT2-Targeted Near-Infrared Optical Imaging Agent for Early-Stage Pulmonary Adenocarcinoma." Molecular Imaging and Biology, vol. 27, no. 4, 2025, p. 558, https://doi.org/10.1007/s11307-025-02029-w.